These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32899606)

  • 21. Chronic inflammatory disorders and accelerated atherosclerosis: chronic kidney disease.
    Navab KD; Elboudwarej O; Gharif M; Yu J; Hama SY; Safarpour S; Hough GP; Vakili L; Reddy ST; Navab M; Vaziri ND
    Curr Pharm Des; 2011; 17(1):17-20. PubMed ID: 21222643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications.
    Cho KH
    BMB Rep; 2009 Jul; 42(7):393-400. PubMed ID: 19643035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal disease.
    Kaysen GA
    Kidney Int; 2009 Aug; 76(4):359-61. PubMed ID: 19644477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-density lipoproteins, inflammation and oxidative stress.
    Tabet F; Rye KA
    Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High density lipoprotein decreases beta-amyloid toxicity in cortical cell culture.
    Farhangrazi ZS; Ying H; Bu G; Dugan LL; Fagan AM; Choi DW; Holtzman DM
    Neuroreport; 1997 Mar; 8(5):1127-30. PubMed ID: 9175098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.
    Vance JE; Hayashi H
    Biochim Biophys Acta; 2010 Aug; 1801(8):806-18. PubMed ID: 20170744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease.
    Besler C; Heinrich K; Riwanto M; Lüscher TF; Landmesser U
    Curr Pharm Des; 2010 May; 16(13):1480-93. PubMed ID: 20196740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti inflammatory effects of high density lipoproteins.
    Murphy AJ; Chin-Dusting JP; Sviridov D; Woollard KJ
    Curr Med Chem; 2009; 16(6):667-75. PubMed ID: 19199930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein-mimetic Peptides: Current and Future Prospectives.
    Nankar SA; Ahmed S; Sharma SS; Pande AH
    Curr Protein Pept Sci; 2022; 23(11):757-772. PubMed ID: 36200201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Density Lipoprotein Subclasses and Mild Cognitive Impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia)1.
    Ohtani R; Nirengi S; Nakamura M; Murase N; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Kotani K; Sakane N
    J Alzheimers Dis; 2018; 66(1):289-296. PubMed ID: 30248050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.
    Ikenaga M; Higaki Y; Saku K; Uehara Y
    J Atheroscler Thromb; 2016; 23(4):385-94. PubMed ID: 26830201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging roles for high-density lipoproteins in neurodegenerative disorders.
    Bahrami A; Barreto GE; Lombardi G; Pirro M; Sahebkar A
    Biofactors; 2019 Sep; 45(5):725-739. PubMed ID: 31301192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection.
    Meyers CD; Kashyap ML
    Curr Opin Cardiol; 2004 Jul; 19(4):366-73. PubMed ID: 15218398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
    Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice.
    Escola-Gil JC; Calpe-Berdiel L; Palomer X; Ribas V; Ordonez-Llanos J; Blanco-Vaca F
    Front Biosci; 2006 May; 11():1328-48. PubMed ID: 16368520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases.
    Van Valkenburgh J; Meuret C; Martinez AE; Kodancha V; Solomon V; Chen K; Yassine HN
    Front Physiol; 2021; 12():700847. PubMed ID: 34552500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models.
    Rader DJ; Ikewaki K
    Curr Opin Lipidol; 1996 Jun; 7(3):117-23. PubMed ID: 8818507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.
    Namiri-Kalantari R; Gao F; Chattopadhyay A; Wheeler AA; Navab KD; Farias-Eisner R; Reddy ST
    Biofactors; 2015 May; 41(3):153-9. PubMed ID: 26072738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
    Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
    J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
    Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
    Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.